Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

HHS launches federal investigation into Cedars-Sinai's treatment of Black mothers

The civil rights probe follows a wrongful death lawsuit filed by Charles Johnson IV after the untimely death of his wife, who had undergone a planned cesarean section in 2016.

the words "FDA recall" on a board

Medtronic recalls nearly 350,000 implantable heart devices after 22 injuries

The FDA has categorized this as a Class I recall, meaning the use of these devices could cause serious injuries or death.”

fda approves first daily oral birth control

FDA approves first nonprescription daily birth control in US

Opill (norgestrel) is a progestin-only daily oral contraceptive that can be purchased without prescription at drug stores, convenience stores, grocery stores and online once it becomes available to consumers.

artificial intelligence healthcare providers legal

3 AI to-do’s for legally aware healthcare providers

Healthcare providers might be the most underrated of all AI stakeholders. Never mind that close to half of 200 CEOs surveyed believe healthcare is the field in which AI is likely to make the most transformative contribution.

Medtronic has received FDA approval for its IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter

FDA says treating PAD with paclitaxel-coated devices does not increase mortality risk

After warning healthcare providers about a heightened risk of mortality back in 2019, the FDA has now updated its stance on the use of these devices. 

brain money alzheimer dementia

Coverage is now available for new Alzheimer's drug

In a July 6 announcement, CMS shared that coverage is officially available for Leqembi for those who meet certain criteria.

Thumbnail

President Biden cracks down on short-term health plans, calls them 'junk insurance'

The proposed rule would require that short-term plans are truly short-term and are active for just three months.

Cost of healthcare expected to increase by 7% in 2024

The estimated increase is driven by multiple factors, including labor shortages, provider contract negotiations and rising drug prices.

Around the web

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

These companies were already part of the Johnson & Johnson family, but they had still retained their previous brand names. Now, each one is officially going by Johnson & Johnson MedTech. 

Trimed Popup
Trimed Popup